Smith Thomas B, EVP and Chief Medical Officer at Collegium Pharmaceutical ($COLL), sold about $672,000 worth of shares in one open market transaction on August 29, 2025, with no purchases in the past year. This ranks 5,841st among nearly 12,000 insiders, well below the average $8.6 million sale across about 6 transactions.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 5897 | $46.75 | 102,189.0000 | 40,076,457 | 5.46% | 0.01% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 22774 | $0.00 | 108,086.0000 | 40,076,457 | 26.69% | 0.06% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 14268 | $0.00 | 85,312.0000 | 40,076,457 | 20.08% | 0.04% |
| Feb. 10, 2026 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 11538 | $46.75 | 90,651.0000 | 40,076,457 | 11.29% | 0.03% |
| Aug. 29, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | S | Common Stock | 17478 | $38.42 | 70,264.0000 | 39,075,703 | 19.92% | 0.04% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 33762 | $0.00 | 88,326.0000 | 40,109,649 | 61.88% | 0.08% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 5313 | $0.00 | 93,639.0000 | 40,109,649 | 6.02% | 0.01% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 1498 | $30.52 | 92,141.0000 | 40,109,649 | 1.60% | 0.00% |
| Feb. 10, 2025 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 4399 | $30.52 | 87,742.0000 | 40,109,649 | 4.77% | 0.01% |
| Sept. 13, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | S | Common Stock | 9593 | $36.62 | 53,816.0000 | 40,383,694 | 15.13% | 0.02% |
| Feb. 29, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | S | Common Stock | 995 | $36.76 | 63,409.0000 | 41,279,981 | 1.54% | 0.00% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 1300 | $33.70 | 64,404.0000 | 41,279,981 | 1.98% | 0.00% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 30800 | $0.00 | 62,980.0000 | 41,279,981 | 95.71% | 0.07% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 4623 | $0.00 | 67,603.0000 | 41,279,981 | 7.34% | 0.01% |
| Feb. 12, 2024 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | F | Common Stock | 1899 | $33.70 | 65,704.0000 | 41,279,981 | 2.81% | 0.00% |
| Feb. 10, 2023 | COLLEGIUM PHARMACEUTICAL, INC | $COLL | Smith Thomas B | EVP and Chief Medical Officer | A | Common Stock | 31185 | $0.00 | 31,185.0000 | 33,582,202 | 9999.99% | 0.09% |